PDEX Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio16.02Forward 19.12
EPS (TTM)$3.63143.4% YoY
Profit margin17.6%HEALTHCARE
Market cap$186.1MMicro cap
Valuation
- Forward P/E
- 19.12
- PEG ratio
- 0.00
- P/B
- 3.83
- P/S (TTM)
- 2.40
- EV/EBITDA
- 11.10
Profitability & growth
- ROE (TTM)
- 32.4%
- Operating margin
- 17.3%
- Revenue growth YoY
- 16.6%
- Dividend yield
- —
- Beta
- 0.04
Last earnings
Oct 29, 2026 · Estimate $0.67 · Reported $0.92
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Pro-Dex Inc
Company profilePro-Dex, Inc. designs, develops and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company is headquartered in Irvine, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 2361 MCGAW AVENUE, IRVINE, CA
- Fiscal year end
- June
- Latest quarter
- Sep 30, 2026
Market cap$186.1M
Shares outstanding$3.2M
52W high$77.00
52W low$28.81
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent